Subscriptions
ES Guidelines Subscription
ES Guidelines Subscription
Last Updated: February 9, 2023
$74.49/ year
Digital Subscription Information:
- Supported on Apple and Android devices
- Content is accessible offline
- Includes automatic updates
Included Guidelines:
- Acromegaly
- Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency
- Cushing’s Syndrome Treatment
- Diabetes and Pregnancy
- Diagnosis of Cushing’s Syndrome
- Evaluation and Treatment of Hypertriglyceridemia
- Functional Hypothalamic Amenorrhea
- Gender-Dysphoria / Gender-Incongruence
- Hirsutism in Premenopausal Women
- Hypercalcemia of Malignancy in Adults
- Hyperglycemia in Hospitalized Adult Patients
- Hypothalamic–Pituitary and Growth Disorders in Survivors of Childhood Cancer
- Lipid Management in Patients with Endocrine Disorders
- Management of Individuals with Diabetes at High Risk for Hypoglycemia
- Menopause
- Obesity
- Paget’s Disease of Bone
- Pediatric Obesity
- Pharmacological Management of Osteoporosis in Postmenopausal Women
- Primary Adrenal Insufficiency
- Primary Aldosteronism
- Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk
- Testosterone Therapy in Men With Hypogonadism
- Treatment of Diabetes in Older Adults
Related Products

Management of Individuals with Diabetes at High Risk for Hypoglycemia
Endocrine Society
Last Updated: Dec 7, 2022
$
9.95
Print

Pharmacological Management of Osteoporosis in Postmenopausal Women
Endocrine Society
Last Updated: Feb 18, 2020
$
9.95
Print

Hypothalamic–Pituitary and Growth Disorders in Survivors of Childhood Cancer
Endocrine Society
Last Updated: Aug 14, 2018
$
9.95
Print

Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk
Endocrine Society
Last Updated: Jan 5, 2015
$
9.95
Print

Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency
Endocrine Society
Last Updated: Oct 22, 2014
$
9.95
Print